BindingDB logo
myBDB logout

null

SMILES: CNCC[C@H](Oc1ccc(CN2CCN(C)c3cc(ncc3C2=O)N(C)C)cc1)c1cccs1

InChI Key: InChIKey=CMVIUAMERNJGJV-QHCPKHFHSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 436608   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103]


(Homo sapiens (Human))
BDBM436608
PNG
((S)-8- (dimethylamino)-1- methyl-4-(4-(3- (methyla...)
Show SMILES CNCC[C@H](Oc1ccc(CN2CCN(C)c3cc(ncc3C2=O)N(C)C)cc1)c1cccs1 |r|
Show InChI InChI=1S/C26H33N5O2S/c1-27-12-11-23(24-6-5-15-34-24)33-20-9-7-19(8-10-20)18-31-14-13-30(4)22-16-25(29(2)3)28-17-21(22)26(31)32/h5-10,15-17,23,27H,11-14,18H2,1-4H3/t23-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
300n/an/an/an/an/an/an/an/a



ESTEVE PHARMACEUTICALS, S.A.

US Patent


Assay Description
α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...


US Patent US10590140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1HGR
More data for this
Ligand-Target Pair
Voltage-dependent calcium channel subunit alpha-2/delta-1 [25-1103]


(Homo sapiens (Human))
BDBM436608
PNG
((S)-8- (dimethylamino)-1- methyl-4-(4-(3- (methyla...)
Show SMILES CNCC[C@H](Oc1ccc(CN2CCN(C)c3cc(ncc3C2=O)N(C)C)cc1)c1cccs1 |r|
Show InChI InChI=1S/C26H33N5O2S/c1-27-12-11-23(24-6-5-15-34-24)33-20-9-7-19(8-10-20)18-31-14-13-30(4)22-16-25(29(2)3)28-17-21(22)26(31)32/h5-10,15-17,23,27H,11-14,18H2,1-4H3/t23-/m0/s1
PDB

UniProtKB/SwissProt

GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
300n/an/an/an/an/an/an/an/a



ESTEVE PHARMACEUTICALS, S.A.

US Patent


Assay Description
α2δ-1: Binding Assay to Human α2δ-1 Subunit of Cav2.2 Calcium Channel.Human α2δ-1 enriched membranes (2.5 μg) were...


US Patent US10590140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1HGR
More data for this
Ligand-Target Pair
Sodium-dependent noradrenaline transporter


(Homo sapiens (Human))
BDBM436608
PNG
((S)-8- (dimethylamino)-1- methyl-4-(4-(3- (methyla...)
Show SMILES CNCC[C@H](Oc1ccc(CN2CCN(C)c3cc(ncc3C2=O)N(C)C)cc1)c1cccs1 |r|
Show InChI InChI=1S/C26H33N5O2S/c1-27-12-11-23(24-6-5-15-34-24)33-20-9-7-19(8-10-20)18-31-14-13-30(4)22-16-25(29(2)3)28-17-21(22)26(31)32/h5-10,15-17,23,27H,11-14,18H2,1-4H3/t23-/m0/s1
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
300n/an/an/an/an/an/an/an/a



ESTEVE PHARMACEUTICALS, S.A.

US Patent


Assay Description
NET: Human norepinephrine transporter (NET) enriched membranes (5 μg) were incubated with 5 nM of radiolabeled [3H]-Nisoxetin in assay buffer co...


US Patent US10590140 (2020)


BindingDB Entry DOI: 10.7270/Q2WM1HGR
More data for this
Ligand-Target Pair